Related Experiment Videos
Parenteral cephalothin therapy for pelvic gonococcal infections
JACEP
|March 1, 1978
Summary
Intravenous cephalothin effectively treated acute pelvic inflammatory disease caused by Neisseria gonorrhoeae. This antibiotic demonstrated rapid clinical improvement and eradicated the bacteria, proving well-tolerated in patients.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Pelvic inflammatory disease (PID) is a significant gynecological infection.
- Neisseria gonorrhoeae is a common causative agent of PID.
- Effective antibiotic treatment is crucial for managing PID.
Purpose of the Study:
- To evaluate the efficacy of intravenous cephalothin in treating acute gonococcal pelvic inflammatory disease.
- To assess the microbiological and clinical outcomes of cephalothin therapy.
Main Methods:
- Prospective study of 20 patients with acute PID.
- Intravenous cephalothin (2 gm every 4 hours for 7 days) administered.
- Blood, cervical, and cul-de-sac cultures performed for Neisseria gonorrhoeae detection.
Main Results:
- Clinical improvement observed within 48 to 78 hours.
- Cervical cultures became negative for Neisseria gonorrhoeae post-treatment.
- Intravenous cephalothin was well-tolerated by all patients.
Conclusions:
- Intravenous cephalothin is an effective and acceptable alternative antibiotic for treating gonococcal pelvic infections.
- The drug demonstrates rapid efficacy and good tolerability in PID patients.